SQ-109 Completed Phase 1 Trials for Multidrug Resistant Tuberculosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00866190
Dose Escalation Study of SQ109 in Healthy Adult Volunteers